Efficacy, Safety, and Economic Impact of Cytisinicline Maintenance Therapy in Patients Who Are Candidates for Smoking Cessation: Protocol for a Phase IV, Multicenter, Randomized, Open-Label, Controlled, Parallel Clinical Trial (CITISILONG Trial)

BackgroundCytisinicline has proven to be an effective, efficient, and safe molecule in smoking cessation. However, the established 25-day regimen could be insufficient in a high percentage of smokers, so it is necessary to study maintained therapies of this drug....

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Carlos Rabade Castedo, Ana Estany-Gestal, Carlos A Jiménez Ruiz, José Ignacio de Granda-Orive, Juan Antonio Riesco-Miranda, María Isabel Cristóbal Fernández, Angela Ramos-Pinedo, Jaime Signes-Costa Miñana, María Inmaculada Gorordo-Unzueta, Agustin Valido-Morales, Jacobo Sellarés -Torres, Eva Cabrera-César, Alejandro Frino-García, Luis Valdés Cuadrado
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	JMIR Publications 2026-01-01
סדרה:	JMIR Research Protocols
גישה מקוונת:	https://www.researchprotocols.org/2026/1/e76815
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!